Brain bleed surgery: does the drill site matter?

NCT ID NCT07731620

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial compares two common puncture sites—frontal region versus parietal eminence—for minimally invasive twist-drill drainage of chronic subdural hematoma (a slow brain bleed common in older adults). The goal is to see which site lowers the risk of the hematoma coming back and needing another surgery within three months. Adults with a unilateral chronic subdural hematoma who need surgical drainage are randomly assigned to one of the two puncture sites and followed for recovery and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
twist-drill puncture and closed-system drainage at either the frontal region or the parietal eminence
What this could lead to
If one puncture site proves better, it could become the standard approach for this common brain-bleed surgery, lowering the chance that patients need a second operation.
What could go wrong
This is a single-center trial, so results may not apply everywhere. The outcome depends on surgical technique and patient anatomy, and recurrence can still happen regardless of site.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huai'an First People's Hospital

    Huai'an, Jiangsu, 223300, China

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230601, China

  • Yangzhou University Affiliated Hospital

    Yangzhou, Jiangsu, 225009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.